文献速递流行病学与生物统计

covid-19患者嗅觉和味觉功能障碍的预后与持续性:恢复曲线的参数治愈模型Meta分析

Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves.
PubMed 文献 · BMJ · 2022-07-27

该系统评价与Meta分析纳入18项观察性研究共3699例成年covid-19患者,重建个体患者时间-事件数据并采用Weibull非混合治愈模型估计持续性嗅觉和味觉障碍比例分别为5.6%和4.4%。180天时嗅觉和味觉恢复率分别为95.7%和98.0%,女性及初始功能障碍严重者嗅觉恢复可能性较低。

要点

  • 估计5.6%和4.4%的covid-19患者可能分别出现持续性自报嗅觉和味觉障碍。
  • 180天时嗅觉恢复率95.7%、味觉恢复率98.0%,恢复多发生在早期。
  • 女性较男性嗅觉恢复可能性低(OR 0.52),味觉恢复可能性亦低(OR 0.31)。

核心结论

  • 相当比例covid-19患者可能出现长期嗅觉或味觉改变,可能加重长covid负担。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Embase、Scopus、Cochrane Library和medRxiv自建库至2021年10月3日。
  • 纳入18项观察性研究共3699例成年covid-19相关嗅觉或味觉功能障碍患者。
  • 采用迭代数值算法重建时间-事件个体患者数据并合并,采用Weibull非混合治愈模型估计持续性障碍比例。
  • 采用QUIPS评估偏倚风险、GRADE评估证据质量,遵循PRISMA和MOOSE报告规范。

主要发现

  • 基于参数治愈模型,持续性自报嗅觉障碍估计为5.6%(95%CI 2.7%至11.0%,I²=70%,τ²=0.756,95%预测区间0.7%至33.5%)。
  • 持续性自报味觉障碍估计为4.4%(95%CI 1.2%至14.6%,I²=67%,τ²=0.684,95%预测区间0.0%至49.0%)。
  • 30、60、90、180天嗅觉恢复率分别为74.1%(95%CI 64.0%至81.3%)、85.8%(77.6%至90.9%)、90.0%(83.3%至94.0%)、95.7%(89.5%至98.3%)(I²=0.0-77.2%,τ²=0.006-0.050)。
  • 30、60、90、180天味觉恢复率分别为78.8%(95%CI 70.5%至84.7%)、87.7%(82.0%至91.6%)、90.3%(83.5%至94.3%)、98.0%(92.2%至95.5%)(I²=0.0-72.1%,τ²=0.000-0.015)。
  • 女性较男性嗅觉恢复可能性低(OR 0.52,95%CI 0.37至0.72,7项研究,I²=20%,τ²=0.0224),味觉恢复可能性亦低(OR 0.31,95%CI 0.13至0.72,7项研究,I²=78%,τ²=0.5121)。

关键数值与推荐

  • 偏倚风险低至中等,排除4项高风险研究后结论未改变;证据质量中至高等。
  • 敏感性分析提示持续性嗅觉和味觉障碍比例可能被低估。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 嗅觉持续性障碍估计异质性I²=70%,95%预测区间0.7%至33.5%。
  • 味觉持续性障碍估计异质性I²=67%,95%预测区间0.0%至49.0%。
  • 女性味觉恢复关联分析异质性I²=78%。
  • 敏感性分析提示持续性障碍比例可能被低估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To clarify in patients with covid-19 the recovery rate of smell and taste, proportion with persistent dysfunction of smell and taste, and prognostic factors associated with recovery of smell and taste. DESIGN: Systematic review and meta-analysis. DATA SOURCES: PubMed, Embase, Scopus, Cochrane Library, and medRxiv from inception to 3 October 2021. REVIEW METHODS: Two blinded reviewers selected observational studies of adults (≥18 years) with covid-19 related dysfunction of smell or taste. Descriptive prognosis studies with time-to-event curves and prognostic association studies of any prognostic factor were included. DATA EXTRACTION AND SYNTHESIS: Two reviewers extracted data, evaluated study bias using QUIPS, and appraised evidence quality using GRADE, following PRISMA and MOOSE reporting guidelines. Using iterative numerical algorithms, time-to-event individual patient data (IPD) were reconstructed and pooled to retrieve distribution-free summary survival curves, with recovery rates reported at 30 day intervals for participants who remained alive. To estimate the proportion with persistent smell and taste dysfunction, cure fractions from Weibull non-mixture cure models of plateaued survival curves were logit transformed and pooled in a two stage meta-analysis. Conventional aggregate data meta-analysis was performed to explore unadjusted associations of prognostic factors with recovery. MAIN OUTCOME MEASURES: The primary outcomes were the proportions of patients remaining with smell or taste dysfunction. Secondary outcomes were the odds ratios of prognostic variables associated with recovery of smell and taste. RESULTS: 18 studies (3699 patients) from 4180 records were included in reconstructed IPD meta-analyses. Risk of bias was low to moderate; conclusions remained unaltered after exclusion of four high risk studies. Evidence quality was moderate to high. Based on parametric cure modelling, persistent self-reported smell and taste dysfunction could develop in an estimated 5.6% (95% confidence interval 2.7% to 11.0%, I2=70%, τ2=0.756, 95% prediction interval 0.7% to 33.5%) and 4.4% (1.2% to 14.6%, I2=67%, τ2=0.684, 95% prediction interval 0.0% to 49.0%) of patients, respectively. Sensitivity analyses suggest these could be underestimates. At 30, 60, 90, and 180 days, respectively, 74.1% (95% confidence interval 64.0% to 81.3%), 85.8% (77.6% to 90.9%), 90.0% (83.3% to 94.0%), and 95.7% (89.5% to 98.3%) of patients recovered their sense of smell (I2=0.0-77.2%, τ2=0.006-0.050) and 78.8% (70.5% to 84.7%), 87.7% (82.0% to 91.6%), 90.3% (83.5% to 94.3%), and 98.0% (92.2% to 95.5%) recovered their sense of taste (range of I2=0.0-72.1%, τ2=0.000-0.015). Women were less likely to recover their sense of smell (odds ratio 0.52, 95% confidence interval 0.37 to 0.72, seven studies, I2=20%, τ2=0.0224) and taste (0.31, 0.13 to 0.72, seven studies, I2=78%, τ2=0.5121) than men, and patients with greater initial severity of dysfunction (0.48, 0.31 to 0.73, five studies, I2=10%, τ2<0.001) or nasal congestion (0.42, 0.18 to 0.97, three studies, I2=0%, τ2<0.001) were less likely to recover their sense of smell. CONCLUSIONS: A substantial proportion of patients with covid-19 might develop long lasting change in their sense of smell or taste. This could contribute to the growing burden of long covid. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42021283922.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Tan BKJ, Han R, Zhao JJ, et al. Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022. PMID: 35896188. doi:10.1136/bmj-2021-069503

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。